Defeating brain cancer requires a delicate balance. At least that’s how Dr. David Stojdl sees it. On the one hand, Dr. Stojdl is engineering viruses that seek out tumour cells in the brain, infect them and flag them as dangerous — yet don’t infect healthy cells. “Brain tissue is not very amenable to… Read more »
Tag: CHEO
World-first clinical trial for oncolytic virus immunotherapy featured by The National
Last night, CBC TV’s The National introduced its audience to a novel clinical trial currently underway in Canada. The trial has been partially enabled by support from BioCanRx to manufacture the engineered viruses being given to the study’s participants. The clinical trial is testing a new investigational therapy called oncolytic virus immunotherapy, which… Read more »
Cancer patients treated in world-first clinical trial of Canadian viral therapy
Clinical Trials, Media release Canadian researchers have launched the world’s first clinical trial of a novel investigational therapy that uses a combination of two viruses to attack and kill cancer cells, and stimulate an anti-cancer immune response. Previous research by this team and others worldwide suggests that this approach could be very powerful, and… Read more »
